Table 2.
Association between APOBEC3A I/D polymorphism and clinicopathological characteristics
| Variables | APOBEC3A | P | ||
|---|---|---|---|---|
| I/I | I/D | D/D | ||
| Age (years) | 0.696 | |||
| ≤50 | 84 | 60 | 2 | |
| >50 | 64 | 42 | 3 | |
| Pathological type | 0.138 | |||
| Ductal | 94 | 74 | 5 | |
| Others | 47 | 25 | 0 | |
| Tumor size (cm) | 0.429 | |||
| ≤2 | 35 | 47 | 1 | |
| >2 | 77 | 79 | 7 | |
| TNM Stage | 0.850 | |||
| I | 19 | 22 | 3 | |
| II | 47 | 48 | 5 | |
| III | 32 | 35 | 3 | |
| IV | 13 | 24 | 2 | |
| Grade | 0.437 | |||
| I | 23 | 21 | 2 | |
| II | 64 | 67 | 7 | |
| III | 14 | 30 | 1 | |
| IV | 0 | 0 | 0 | |
| ER status | 0.858 | |||
| Positive | 68 | 78 | 8 | |
| Negative | 37 | 43 | 3 | |
| PgR status | 0.627 | |||
| Positive | 62 | 79 | 6 | |
| Negative | 41 | 42 | 5 | |
| HER2 status | 0.155 | |||
| Positive | 50 | 69 | 9 | |
| Negative | 61 | 59 | 4 | |